Dihydrotanshinone, cryptotanshinone, Tan I, and Tan IIA, as new acetylcholinesterase (AChE) inhibitors, have the potential to penetrate the blood–brain barrier and may be used to treat Alzheimer’s disease [81]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.